OMass Technologies
Viviane Mignone is a Senior Scientist II at OMass Therapeutics with experience in investigating RTK pharmacology on endothelial cells. Viviane has a PhD in Cell Biology and Anatomy from UERJ and has worked as a postdoctoral fellow at the University of Nottingham and Universidade do Estado do Rio de Janeiro. Viviane's research focuses on the effects of the extracellular matrix produced by smooth muscle vascular cells on atherosclerosis development.
OMass Technologies
1 followers
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.